1. Sadagopan NS, Gomez M, Tripathi S, Billingham LK, DeLay SL, Cady MA, Congivaram HTS, Chia TY, Wan H, Wang S, Raleigh DR, Kaluba FC, Lien EC, Heimberger AB, Lee-Chang C, Youngblood MW, Magill ST, Miska JM. NOTCH3 Drives Fatty Acid Oxidation and Ferroptosis Resistance in. Res Sq. 2025 Jun 4; PubMed PMID: 40502769; PubMed Central PMCID: PMC12155216.

2. Hou D, Wang S, Castro BA, Katz JL, Dapash M, Arrieta VA, Vazquez-Cervantes GI, Wan H, Billingham LK, Du R, Murphy AR, Lopez-Rosas A, Han Y, Patel RV, Chia TY, Dmello CC, Zhang P, Sheppard D, Sonabend AM, Miska JM, Lesniak MS, Heiland DH, Lee-Chang C. Dual alphaVbeta8 Integrin and PD-1 Blockade Overcomes TGFbeta-Mediated. Neuro Oncol. 2025 Apr 22; PubMed PMID: 40269603;

3. Chia TY, Sadagopan NS, Miska J. Lipid peroxidation and immune activation: TRAF3's double-edged strategy. J Clin Invest. 2025 Apr 1; PubMed PMID: 40166928; PubMed Central PMCID: PMC11957689.

4. Tiek D, Song X, Yu X, Wu R, Iglesia R, Catezone A, McCortney K, Walshon J, Horbinski C, Jamshidi P, Castellani R, Vassar R, Miska J, Hu B, Cheng SY. Oxidative stress induced protein aggregation via GGCT produced. iScience. 2025 Feb 21; PubMed PMID: 39949960; PubMed Central PMCID: PMC11821397.

5. Zannikou MZ, Duffy JT, Procissi D, Najem H, Levine RN, Hambardzumyan D, Lee-Chang C, Leoni L, Zhang B, Heimberger AB, Miska J, Balyasnikova IV. A Bi-Specific T Cell-Engaging Antibody Shows Potent Activity,. bioRxiv. 2025 Jan 29; PubMed PMID: 39763755; PubMed Central PMCID: PMC11702671.

6. Stoolman JS, Grant RA, Billingham LK, Poor TA, Weinberg SE, Harding MC, Lu Z, Miska J, Szibor M, Budinger GS, Chandel NS. Mitochondria complex III-generated superoxide is essential for IL-10. Sci Adv. 2025 Jan 24; PubMed PMID: 39841842; PubMed Central PMCID: PMC11753406.

7. Geng Y, DeLay SL, Chen X, Miska J. It Is Not Just About Storing Energy: The Multifaceted Role of Creatine. Int J Mol Sci. 2024 Dec 11; PubMed PMID: 39769038; PubMed Central PMCID: PMC11678534.

8. Seblani M, Zannikou M, Duffy J, Levine R, Thakur A, Puigdelloses-Vallcorba M, Horbinski C, Miska J, Hambardzumyan D, Becher O, Balyasnikova I. IL13RA2-integrated genetically engineered mouse model allows for CAR T. Res Sq. 2024 Dec 11; PubMed PMID: 39711568; PubMed Central PMCID: PMC11661357.

9. Kim KS, Habashy K, Gould A, Zhao J, Najem H, Amidei C, Saganty R, Arrieta VA, Dmello C, Chen L, Zhang DY, Castro B, Billingham L, Levey D, Huber O, Marques M, Savitsky DA, Morin BM, Muzzio M, Canney M, Horbinski C, Zhang P, Miska J, Padney S, Zhang B, Rabadan R, Phillips JJ, Butowski N, Heimberger AB, Hu J, Stupp R, Chand D, Lee-Chang C, Sonabend AM. Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated. Neuro Oncol. 2024 Nov 4; PubMed PMID: 39028616; PubMed Central PMCID: PMC11534315.

10. Katz JL, Geng Y, Billingham LK, Sadagopan NS, DeLay SL, Subbiah J, Chia TY, McManus G, Wei C, Wang H, Lin H, Silvers C, Boland LK, Wang S, Wan H, Hou D, Vazquez-Cervantes GI, Arjmandi T, Shaikh ZH, Zhang P, Ahmed AU, Tiek DM, Lee-Chang C, Chouchani ET, Miska J. A covalent creatine kinase inhibitor ablates glioblastoma migration and. Sci Rep. 2024 Sep 20; PubMed PMID: 39304717; PubMed Central PMCID: PMC11415369.

11. Panek WK, Toedebusch RG, Mclaughlin BE, Dickinson PJ, Van Dyke JE, Woolard KD, Berens ME, Lesniak MS, Sturges BK, Vernau KM, Li C, Miska J, Toedebusch CM. The CCL2-CCR4 axis promotes Regulatory T cell trafficking to canine. J Neurooncol. 2024 Sep; PubMed PMID: 39046599; PubMed Central PMCID: PMC11341612.

12. Wang S, Castro BA, Katz JL, Arrieta V, Najem H, Vazquez-Cervantes GI, Wan H, Olson IE, Hou D, Dapash M, Billingham LK, Chia TY, Wei C, Rashidi A, Platanias LC, McCortney K, Horbinski CM, Stupp R, Zhang P, Ahmed AU, Sonabend AM, Heimberger AB, Lesniak MS, Riviere-Cazaux C, Burns T, Miska J, Fischietti M, Lee-Chang C. B cell-based therapy produces antibodies that inhibit glioblastoma. J Clin Invest. 2024 Aug 29; PubMed PMID: 39207859; PubMed Central PMCID: PMC11473152.

13. Arrieta VA, Gould A, Kim KS, Habashy KJ, Dmello C, Vazquez-Cervantes GI, Palacin-Aliana I, McManus G, Amidei C, Gomez C, Dhiantravan S, Chen L, Zhang DY, Saganty R, Cholak ME, Pandey S, McCord M, McCortney K, Castro B, Ward R, Muzzio M, Bouchoux G, Desseaux C, Canney M, Carpentier A, Zhang B, Miska JM, Lesniak MS, Horbinski CM, Lukas RV, Stupp R, Lee-Chang C, Sonabend AM. Ultrasound-mediated delivery of doxorubicin to the brain results in. Nat Commun. 2024 Jun 6; PubMed PMID: 38844770; PubMed Central PMCID: PMC11156895.

14. Faisal SM, Ravi VM, Miska JM. Editorial: Spatiotemporal heterogeneity in CNS tumors. Front Immunol. 2024; PubMed PMID: 38868775; PubMed Central PMCID: PMC11167105.

15. Chen S, Fan J, Xie P, Ahn J, Fernandez M, Billingham LK, Miska J, Wu JD, Wainwright DA, Fang D, Sosman JA, Wan Y, Zhang Y, Chandel NS, Zhang B. CD8+ T cells sustain antitumor response by mediating crosstalk between. J Clin Invest. 2024 Mar 5; PubMed PMID: 38441967; PubMed Central PMCID: PMC11014673.

16. Khan F, Lin Y, Ali H, Pang L, Dunterman M, Hsu WH, Frenis K, Grant Rowe R, Wainwright DA, McCortney K, Billingham LK, Miska J, Horbinski C, Lesniak MS, Chen P. Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote. Nat Commun. 2024 Mar 5; PubMed PMID: 38443336; PubMed Central PMCID: PMC10914854.

17. Tripathi S, Najem H, Dussold C, Pacheco S, Miska J, McCortney K, Steffens A, Walshon J, Winkowski D, Cloney M, Ordon M, Gibson W, Kemeny H, Youngblood M, Du R, Mossner J, Texakalidis P, Sprau A, Tate M, James CD, Horbinski CM, Wadhwani NR, Lesniak MS, Lam S, Sati A, Aghi M, DeCuypere M, Heimberger AB. Cancer-associated fibroblast-secreted collagen is associated with immune. J Clin Invest. 2024 Feb 15; PubMed PMID: 38357919; PubMed Central PMCID: PMC10866651.

18. Collado J, Boland L, Ahrendsen JT, Miska J, Lee-Chang C. Understanding the glioblastoma tumor microenvironment: leveraging the. Front Immunol. 2024; PubMed PMID: 38380331; PubMed Central PMCID: PMC10876826.

19. Najem H, Arrieta VA, Duffy J, Tripathi S, Zannikou M, Dhiantravan S, Miska J, McCortney K, Steffens A, Walshon J, Lee Chang C, Dahdaleh NS, Sonabend AM, Smith Z, Horbinski CM, Chandler J, Heimberger AB, Balyasnikova IV. Prohibitin Expression in Antigen-Presenting Cells: Implications for. Ann Case Rep. 2024; PubMed PMID: 38606301; PubMed Central PMCID: PMC11008565.

20. Dussold C, Zilinger K, Turunen J, Heimberger AB, Miska J. Modulation of macrophage metabolism as an emerging immunotherapy strategy. J Clin Invest. 2024 Jan 16; PubMed PMID: 38226622; PubMed Central PMCID: PMC10786697.

21. Rashidi A, Billingham LK, Zolp A, Chia TY, Silvers C, Katz JL, Park CH, Delay S, Boland L, Geng Y, Markwell SM, Dmello C, Arrieta VA, Zilinger K, Jacob IM, Lopez-Rosas A, Hou D, Castro B, Steffens AM, McCortney K, Walshon JP, Flowers MS, Lin H, Wang H, Zhao J, Sonabend A, Zhang P, Ahmed AU, Brat DJ, Heiland DH, Lee-Chang C, Lesniak MS, Chandel NS, Miska J. Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma. Cell Metab. 2024 Jan 2; PubMed PMID: 38134929; PubMed Central PMCID: PMC10842612.

22. Fares J, Petrosyan E, Kanojia D, Dmello C, Cordero A, Duffy JT, Yeeravalli R, Sahani MH, Zhang P, Rashidi A, Arrieta VA, Ulasov I, Ahmed AU, Miska J, Balyasnikova IV, James CD, Sonabend AM, Heimberger AB, Lesniak MS. Metixene is an incomplete autophagy inducer in preclinical models of. J Clin Invest. 2023 Dec 15; PubMed PMID: 37847564; PubMed Central PMCID: PMC10721147.

23. Zhang P, Miska J, Heimberger AB. GLUT3 regulates alternative macrophage signaling through a glucose. J Clin Invest. 2023 Nov 1; PubMed PMID: 37909335; PubMed Central PMCID: PMC10617759.

24. Riviere-Cazaux C, Neth BJ, Hoplin MD, Wessel B, Miska J, Kizilbash SH, Burns TC. Glioma Metabolic Feedback In Situ: A First-In-Human Pharmacodynamic Trial. Neurosurgery. 2023 Oct 1; PubMed PMID: 37246885; PubMed Central PMCID: PMC10637404.

25. Takata N, Miska JM, Morgan MA, Patel P, Billingham LK, Joshi N, Schipma MJ, Dumar ZJ, Joshi NR, Misharin AV, Embry RB, Fiore L, Gao P, Diebold LP, McElroy GS, Shilatifard A, Chandel NS, Oliver G. Lactate-dependent transcriptional regulation controls mammalian eye. Nat Commun. 2023 Jul 14; PubMed PMID: 37452018; PubMed Central PMCID: PMC10349100.

26. Perrault EN, Shireman JM, Ali ES, Lin P, Preddy I, Park C, Budhiraja S, Baisiwala S, Dixit K, James CD, Heiland DH, Ben-Sahra I, Pott S, Basu A, Miska J, Ahmed AU. Ribonucleotide reductase regulatory subunit M2 drives glioblastoma TMZ. Sci Adv. 2023 May 19; PubMed PMID: 37196077; PubMed Central PMCID: PMC10191446.

27. Petrosyan E, Fares J, Fernandez LG, Yeeravalli R, Dmello C, Duffy JT, Zhang P, Lee-Chang C, Miska J, Ahmed AU, Sonabend AM, Balyasnikova IV, Heimberger AB, Lesniak MS. Endoplasmic Reticulum Stress in the Brain Tumor Immune Microenvironment. Mol Cancer Res. 2023 May 1; PubMed PMID: 36652630; PubMed Central PMCID: PMC10159901.

28. Zhang P, Rashidi A, Zhao J, Silvers C, Wang H, Castro B, Ellingwood A, Han Y, Lopez-Rosas A, Zannikou M, Dmello C, Levine R, Xiao T, Cordero A, Sonabend AM, Balyasnikova IV, Lee-Chang C, Miska J, Lesniak MS. STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate. Nat Commun. 2023 Mar 23; PubMed PMID: 36959214; PubMed Central PMCID: PMC10036562.

29. Dmello C, Zhao J, Chen L, Gould A, Castro B, Arrieta VA, Zhang DY, Kim KS, Kanojia D, Zhang P, Miska J, Yeeravalli R, Habashy K, Saganty R, Kang SJ, Fares J, Liu C, Dunn G, Bartom E, Schipma MJ, Hsu PD, Alghamri MS, Lesniak MS, Heimberger AB, Rabadan R, Lee-Chang C, Sonabend AM. Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response. Nat Commun. 2023 Mar 22; PubMed PMID: 36949040; PubMed Central PMCID: PMC10033639.

30. Zannikou M, Duffy JT, Levine RN, Seblani M, Liu Q, Presser A, Arrieta VA, Chen CJ, Sonabend AM, Horbinski CM, Lee-Chang C, Miska J, Lesniak MS, Gottschalk S, Balyasnikova IV. IL15 modification enables CAR T cells to act as a dual targeting agent. J Immunother Cancer. 2023 Feb; PubMed PMID: 36759014; PubMed Central PMCID: PMC9923337.

31. Hou D, Castro B, Dapash M, Zolp A, Katz J, Arrieta V, Biermann J, Melms J, Kueckelhaus J, Benotmane J, Youngblood M, Rashidi A, Billingham L, Dmello C, Vazquez-Cervantes G, Lopez-Rosas A, Han Y, Patel R, Chia TY, Sun L, Prins R, Izar B, Heiland DH, Zhang P, Sonabend A, Miska J, Lesniak M, Zhao J, Lee-Chang C. B-cells Drive Response to PD-1 Blockade in Glioblastoma Upon. Res Sq. 2023 Jan 9; PubMed PMID: 36711497; PubMed Central PMCID: PMC9882679.

32. Miska J, Chandel NS. Targeting fatty acid metabolism in glioblastoma. J Clin Invest. 2023 Jan 3; PubMed PMID: 36594473; PubMed Central PMCID: PMC9797338.

33. Preddy I, Nandoliya K, Miska J, Ahmed AU. Checkpoint: Inspecting the barriers in glioblastoma immunotherapies. Semin Cancer Biol. 2022 Nov; PubMed PMID: 35150865; PubMed Central PMCID: PMC9363531.

34. Cao TQ, Wainwright DA, Lee-Chang C, Miska J, Sonabend AM, Heimberger AB, Lukas RV. Next Steps for Immunotherapy in Glioblastoma. Cancers (Basel). 2022 Aug 20; PubMed PMID: 36011015; PubMed Central PMCID: PMC9406905.

35. Petrosyan E, Fares J, Cordero A, Rashidi A, Arrieta VA, Kanojia D, Lesniak MS. Repurposing autophagy regulators in brain tumors. International journal of cancer. 2022 Jul 15; PubMed PMID: 35179776; PubMed Central PMCID: PMC9133056.

36. Larkin CJ, Arrieta VA, Najem H, Li G, Zhang P, Miska J, Chen P, James CD, Sonabend AM, Heimberger AB. Myeloid Cell Classification and Therapeutic Opportunities Within the. Front Immunol. 2022; PubMed PMID: 35784281; PubMed Central PMCID: PMC9244707.

37. Billingham LK, Stoolman JS, Vasan K, Rodriguez AE, Poor TA, Szibor M, Jacobs HT, Reczek CR, Rashidi A, Zhang P, Miska J, Chandel NS. Mitochondrial electron transport chain is necessary for NLRP3. Nat Immunol. 2022 May; PubMed PMID: 35484407; PubMed Central PMCID: PMC9098388.

38. Chia TY, Zolp A, Miska J. Polyamine Immunometabolism: Central Regulators of Inflammation, Cancer. Cells. 2022 Mar 5; PubMed PMID: 35269518; PubMed Central PMCID: PMC8909056.

39. Cordero A, Ramsey MD, Kanojia D, Fares J, Petrosyan E, Schwartz CW, Burga R, Zhang P, Rashidi A, Castro B, Xiao T, Lee-Chang C, Miska J, Balyasnikova IV, Ahmed AU, Lesniak MS. Combination of tucatinib and neural stem cells secreting anti-HER2. Proc Natl Acad Sci U S A. 2022 Jan 4; PubMed PMID: 34969858; PubMed Central PMCID: PMC8740706.

40. Fares J, Ahmed AU, Ulasov IV, Sonabend AM, Miska J, Lee-Chang C, Balyasnikova IV, Chandler JP, Portnow J, Tate MC, Kumthekar P, Lukas RV, Grimm SA, Adams AK, Hebert CD, Strong TV, Amidei C, Arrieta VA, Zannikou M, Horbinski C, Zhang H, Burdett KB, Curiel DT, Sachdev S, Aboody KS, Stupp R, Lesniak MS. Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed. Lancet Oncol. 2021 Aug; PubMed PMID: 34214495; PubMed Central PMCID: PMC8328944.

41. Shireman JM, Atashi F, Lee G, Ali ES, Saathoff MR, Park CH, Savchuk S, Baisiwala S, Miska J, Lesniak MS, James CD, Stupp R, Kumthekar P, Horbinski CM, Ben-Sahra I, Ahmed AU. De novo purine biosynthesis is a major driver of chemoresistance in. Brain. 2021 May 7; PubMed PMID: 33855339; PubMed Central PMCID: PMC8105035.

42. Miska J, Rashidi A, Lee-Chang C, Gao P, Lopez-Rosas A, Zhang P, Burga R, Castro B, Xiao T, Han Y, Hou D, Sampat S, Cordero A, Stoolman JS, Horbinski CM, Burns M, Reshetnyak YK, Chandel NS, Lesniak MS. Polyamines drive myeloid cell survival by buffering intracellular pH to. Sci Adv. 2021 Feb; PubMed PMID: 33597238; PubMed Central PMCID: PMC7888943.

43. Lee-Chang C, Miska J, Hou D, Rashidi A, Zhang P, Burga RA, Jusue-Torres I, Xiao T, Arrieta VA, Zhang DY, Lopez-Rosas A, Han Y, Sonabend AM, Horbinski CM, Stupp R, Balyasnikova IV, Lesniak MS. Activation of 4-1BBL+ B cells with CD40 agonism and IFNgamma elicits. J Exp Med. 2021 Jan 4; PubMed PMID: 32991668; PubMed Central PMCID: PMC7527974.

44. Caragher S, Miska J, Shireman J, Park CH, Muroski M, Lesniak MS, Ahmed AU. Temozolomide Treatment Increases Fatty Acid Uptake in Glioblastoma Stem. Cancers (Basel). 2020 Oct 26; PubMed PMID: 33114573; PubMed Central PMCID: PMC7693784.

45. Kanojia D, Panek WK, Cordero A, Fares J, Xiao A, Savchuk S, Kumar K, Xiao T, Pituch KC, Miska J, Zhang P, Kam KL, Horbinski C, Balyasnikova IV, Ahmed AU, Lesniak MS. BET inhibition increases betaIII-tubulin expression and sensitizes. Science translational medicine. 2020 Aug 26; PubMed PMID: 32848091; PubMed Central PMCID: PMC8276250.

46. Kane JR, Zhao J, Tsujiuchi T, Laffleur B, Arrieta VA, Mahajan A, Rao G, Mela A, Dmello C, Chen L, Zhang DY, Gonzalez-Buendia E, Lee-Chang C, Xiao T, Rothschild G, Basu U, Horbinski C, Lesniak MS, Heimberger AB, Rabadan R, Canoll P, Sonabend AM. CD8(+) T-cell-Mediated Immunoediting Influences Genomic Evolution and. Clinical cancer research : an official journal of the American. 2020 Aug 15; PubMed PMID: 32430477; PubMed Central PMCID: PMC7442699.

47. Poropatich K, Dominguez D, Chan WC, Andrade J, Zha Y, Wray B, Miska J, Qin L, Cole L, Coates S, Patel U, Samant S, Zhang B. OX40+ plasmacytoid dendritic cells in the tumor microenvironment promote. J Clin Invest. 2020 Jul 1; PubMed PMID: 32182225; PubMed Central PMCID: PMC7324178.

48. Rashidi A, Miska J, Lee-Chang C, Kanojia D, Panek WK, Lopez-Rosas A, Zhang P, Han Y, Xiao T, Pituch KC, Kim JW, Talebian M, Fares J, Lesniak MS. GCN2 is essential for CD8(+) T cell survival and function in murine. Cancer Immunol Immunother. 2020 Jan; PubMed PMID: 31844909; PubMed Central PMCID: PMC6952559.

49. Lee-Chang C, Rashidi A, Miska J, Zhang P, Pituch KC, Hou D, Xiao T, Fischietti M, Kang SJ, Appin CL, Horbinski C, Platanias LC, Lopez-Rosas A, Han Y, Balyasnikova IV, Lesniak MS. Myeloid-Derived Suppressive Cells Promote B cell-Mediated. Cancer Immunol Res. 2019 Dec; PubMed PMID: 31530559; PubMed Central PMCID: PMC6891201.

50. Zhang P, Miska J, Lee-Chang C, Rashidi A, Panek WK, An S, Zannikou M, Lopez-Rosas A, Han Y, Xiao T, Pituch KC, Kanojia D, Balyasnikova IV, Lesniak MS. Therapeutic targeting of tumor-associated myeloid cells synergizes with. Proc Natl Acad Sci U S A. 2019 Nov 19; PubMed PMID: 31712430; PubMed Central PMCID: PMC6876152.

51. Fares J, Kanojia D, Cordero A, Rashidi A, Miska J, Schwartz CW, Savchuk S, Ahmed AU, Balyasnikova IV, Cristofanilli M, Gradishar WJ, Lesniak MS. Current state of clinical trials in breast cancer brain metastases. Neuro-oncology practice. 2019 Sep; PubMed PMID: 31555454; PubMed Central PMCID: PMC6753353.

52. Cordero A, Kanojia D, Miska J, Panek WK, Xiao A, Han Y, Bonamici N, Zhou W, Xiao T, Wu M, Ahmed AU, Lesniak MS. FABP7 is a key metabolic regulator in HER2+ breast cancer brain. Oncogene. 2019 Sep; PubMed PMID: 31324889; PubMed Central PMCID: PMC6742563.

53. Panek WK, Pituch KC, Miska J, Kim JW, Rashidi A, Kanojia D, Lopez-Rosas A, Han Y, Yu D, Chang CL, Kane JR, Zhang P, Cordero A, Lesniak MS. Local Application of Autologous Platelet-Rich Fibrin Patch (PRF-P). Molecular neurobiology. 2019 Jul; PubMed PMID: 30460615; PubMed Central PMCID: PMC6527506.

54. Miska J, Lee-Chang C, Rashidi A, Muroski ME, Chang AL, Lopez-Rosas A, Zhang P, Panek WK, Cordero A, Han Y, Ahmed AU, Chandel NS, Lesniak MS. HIF-1alpha Is a Metabolic Switch between Glycolytic-Driven Migration and. Cell reports. 2019 Apr 2; PubMed PMID: 30943404; PubMed Central PMCID: PMC6461402.

55. Wu M, Miska J, Xiao T, Zhang P, Kane JR, Balyasnikova IV, Chandler JP, Horbinski CM, Lesniak MS. Race influences survival in glioblastoma patients with KPS >/= 80 and. J Neurooncol. 2019 Apr; PubMed PMID: 30706176; PubMed Central PMCID: PMC6450757.

56. Caragher SP, Shireman JM, Huang M, Miska J, Atashi F, Baisiwala S, Hong Park C, Saathoff MR, Warnke L, Xiao T, Lesniak MS, James CD, Meltzer H, Tryba AK, Ahmed AU. Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic. The Journal of neuroscience : the official journal of the Society for. 2019 Mar 13; PubMed PMID: 30651332; PubMed Central PMCID: PMC6507082.

57. Wu C, Muroski ME, Miska J, Lee-Chang C, Shen Y, Rashidi A, Zhang P, Xiao T, Han Y, Lopez-Rosas A, Cheng Y, Lesniak MS. Repolarization of myeloid derived suppressor cells via magnetic. Nanomedicine. 2019 Feb; PubMed PMID: 30553919;

58. Kaverina NV, Kadagidze ZG, Borovjagin AV, Karseladze AI, Kim CK, Lesniak MS, Miska J, Zhang P, Baryshnikova MA, Xiao T, Ornelles D, Cobbs C, Khramtsov A, Ulasov IV. Tamoxifen overrides autophagy inhibition in Beclin-1-deficient glioma. Oncogene. 2018 Nov; PubMed PMID: 29991800;

59. Kim JW, Kane JR, Panek WK, Young JS, Rashidi A, Yu D, Kanojia D, Hasan T, Miska J, Gomez-Lim MA, Ulasov IV, Balyasnikova IV, Ahmed AU, Wainwright DA, Lesniak MS. A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune. Neurotherapeutics. 2018 Oct; PubMed PMID: 30027430; PubMed Central PMCID: PMC6277295.

60. Pituch KC, Miska J, Krenciute G, Panek WK, Li G, Rodriguez-Cruz T, Wu M, Han Y, Lesniak MS, Gottschalk S, Balyasnikova IV. Adoptive Transfer of IL13Ralpha2-Specific Chimeric Antigen Receptor T. Mol Ther. 2018 Apr 4; PubMed PMID: 29503195; PubMed Central PMCID: PMC6079480.

61. Miska J, Lui JB, Toomer KH, Devarajan P, Cai X, Houghton J, Lopez DM, Abreu MT, Wang G, Chen Z. Initiation of inflammatory tumorigenesis by CTLA4 insufficiency due to. J Exp Med. 2018 Mar 5; PubMed PMID: 29374027; PubMed Central PMCID: PMC5839767.

62. Muroski ME, Miska J, Chang AL, Zhang P, Rashidi A, Moore H, Lopez-Rosas A, Han Y, Lesniak MS. Fatty Acid Uptake in T Cell Subsets Using a Quantum Dot Fatty Acid. Sci Rep. 2017 Jul 19; PubMed PMID: 28724939; PubMed Central PMCID: PMC5517517.

63. Kim JW, Miska J, Young JS, Rashidi A, Kane JR, Panek WK, Kanojia D, Han Y, Balyasnikova IV, Lesniak MS. A Comparative Study of Replication-Incompetent and -Competent Adenoviral. Molecular therapy oncolytics. 2017 Jun 16; PubMed PMID: 28573184; PubMed Central PMCID: PMC5443908.

64. Miska J, Rashidi A, Chang AL, Muroski ME, Han Y, Zhang L, Lesniak MS. Anti-GITR therapy promotes immunity against malignant glioma in a murine. Cancer Immunol Immunother. 2016 Dec; PubMed PMID: 27734112; PubMed Central PMCID: PMC5101166.

65. Chang AL, Miska J, Wainwright DA, Dey M, Rivetta CV, Yu D, Kanojia D, Pituch KC, Qiao J, Pytel P, Han Y, Wu M, Zhang L, Horbinski CM, Ahmed AU, Lesniak MS. CCL2 Produced by the Glioma Microenvironment Is Essential for the. Cancer research. 2016 Oct 1; PubMed PMID: 27530322; PubMed Central PMCID: PMC5050119.

66. Kim JW, Auffinger B, Spencer DA, Miska J, Chang AL, Kane JR, Young JS, Kanojia D, Qiao J, Mann JF, Zhang L, Wu M, Ahmed AU, Aboody KS, Strong TV, Hebert CD, Lesniak MS. Single dose GLP toxicity and biodistribution study of a conditionally. J Transl Med. 2016 May 16; PubMed PMID: 27184224; PubMed Central PMCID: PMC4868110.

67. Kim JW, Kane JR, Young JS, Chang AL, Kanojia D, Morshed RA, Miska J, Ahmed AU, Balyasnikova IV, Han Y, Zhang L, Curiel DT, Lesniak MS. A Genetically Modified Adenoviral Vector with a Phage Display-Derived. Hum Gene Ther. 2015 Sep; PubMed PMID: 26058317; PubMed Central PMCID: PMC4575547.

68. Miska J, Lesniak MS. Neural Stem Cell Carriers for the Treatment of Glioblastoma Multiforme. EBioMedicine. 2015 Aug; PubMed PMID: 26425671; PubMed Central PMCID: PMC4563132.

69. Qiao J, Dey M, Chang AL, Kim JW, Miska J, Ling A, M Nettlebeck D, Han Y, Zhang L, Lesniak MS. Intratumoral oncolytic adenoviral treatment modulates the glioma. Oncoimmunology. 2015 Aug; PubMed PMID: 26405578; PubMed Central PMCID: PMC4570114.

70. Dey M, Chang AL, Miska J, Wainwright DA, Ahmed AU, Balyasnikova IV, Pytel P, Han Y, Tobias A, Zhang L, Qiao J, Lesniak MS. Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than. J Immunol. 2015 Jul 1; PubMed PMID: 26026061; PubMed Central PMCID: PMC4475664.

71. Kanojia D, Morshed RA, Zhang L, Miska JM, Qiao J, Kim JW, Pytel P, Balyasnikova IV, Lesniak MS, Ahmed AU. betaIII-Tubulin Regulates Breast Cancer Metastases to the Brain. Mol Cancer Ther. 2015 May; PubMed PMID: 25724666; PubMed Central PMCID: PMC4425587.

72. Kane JR, Miska J, Young JS, Kanojia D, Kim JW, Lesniak MS. Sui generis: gene therapy and delivery systems for the treatment of. Neuro Oncol. 2015 Mar; PubMed PMID: 25746089; PubMed Central PMCID: PMC4483038.

73. Devarajan P, Miska J, Lui JB, Swieboda D, Chen Z. Opposing effects of CTLA4 insufficiency on regulatory versus conventional. J Immunol. 2014 Nov 1; PubMed PMID: 25246499; PubMed Central PMCID: PMC4201963.

74. Miska J, Abdulreda MH, Devarajan P, Lui JB, Suzuki J, Pileggi A, Berggren PO, Chen Z. Real-time immune cell interactions in target tissue during autoimmune-. J Exp Med. 2014 Mar 10; PubMed PMID: 24567447; PubMed Central PMCID: PMC3949570.

75. Miska J, Devarajan P, Chen Z. The immunological identity of tumor: Self implications. Oncoimmunology. 2013 Apr 1; PubMed PMID: 23734327; PubMed Central PMCID: PMC3654597.

76. Miska J, Bas E, Devarajan P, Chen Z. Autoimmunity-mediated antitumor immunity: tumor as an immunoprivileged. European journal of immunology. 2012 Oct; PubMed PMID: 22777737;